Global Multiplex Molecular Diagnostic 麻豆原创 Research Report 2023

Publication ID:

PB510231946

Publication Date:

October 19, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Since last few years, research and development of multiplex molecular diagnostics test in clinical microbiology have allowed many laboratories around the world to grow more rapidly and with ease. This has also helped many of these institution to analyze these pathogens directly using multiplex molecular diagnostics in clinical specimens. Above all, recent developments such as approval from USFDA to analyze multiple organisms in single run is helping the market of molecular diagnostic panels to flourish. Using multiplex molecular diagnostics tools, researchers and laboratory personals are able to identify most common laboratory pathogens in gastrointestinal and respiratory more effectively. The w respiratory viral, gastrointestinal, or central nervous system infections.
The global Multiplex Molecular Diagnostic market is projected to reach US$ 8522.7 million in 2029, increasing from US$ 5362 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multiplex Molecular Diagnostic market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiplex Molecular Diagnostic market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
BD
产颈辞惭茅谤颈别耻虫
SpeeDx
Roche
Contextual Genomics
GenMark Diagnostics
Hologic
Luminex Corporation
Binx Health
Segment by Type
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Segment by Application
Clinical Research Laboratory
Hospitals
Academic and Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Multiplex Molecular Diagnostic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Multiplex Molecular Diagnostic 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Real-time PCR
1.2.3 Nested PCR with Melt Curve Analysis
1.2.4 PCR with Low density Microarray
1.2.5 PCR with Liquid Phase Bead Array
1.2.6 PCR with Electrochemical Detection
1.3 麻豆原创 by Application
1.3.1 Global Multiplex Molecular Diagnostic 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Research Laboratory
1.3.3 Hospitals
1.3.4 Academic and Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiplex Molecular Diagnostic 麻豆原创 Perspective (2018-2029)
2.2 Multiplex Molecular Diagnostic Growth Trends by Region
2.2.1 Global Multiplex Molecular Diagnostic 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multiplex Molecular Diagnostic Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Multiplex Molecular Diagnostic Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Multiplex Molecular Diagnostic 麻豆原创 Dynamics
2.3.1 Multiplex Molecular Diagnostic Industry Trends
2.3.2 Multiplex Molecular Diagnostic 麻豆原创 Drivers
2.3.3 Multiplex Molecular Diagnostic 麻豆原创 Challenges
2.3.4 Multiplex Molecular Diagnostic 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplex Molecular Diagnostic Players by Revenue
3.1.1 Global Top Multiplex Molecular Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Multiplex Molecular Diagnostic Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Multiplex Molecular Diagnostic 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiplex Molecular Diagnostic Revenue
3.4 Global Multiplex Molecular Diagnostic 麻豆原创 Concentration Ratio
3.4.1 Global Multiplex Molecular Diagnostic 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex Molecular Diagnostic Revenue in 2022
3.5 Multiplex Molecular Diagnostic Key Players Head office and Area Served
3.6 Key Players Multiplex Molecular Diagnostic Product Solution and Service
3.7 Date of Enter into Multiplex Molecular Diagnostic 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex Molecular Diagnostic Breakdown Data by Type
4.1 Global Multiplex Molecular Diagnostic Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Multiplex Molecular Diagnostic Forecasted 麻豆原创 Size by Type (2024-2029)
5 Multiplex Molecular Diagnostic Breakdown Data by Application
5.1 Global Multiplex Molecular Diagnostic Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Multiplex Molecular Diagnostic Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Multiplex Molecular Diagnostic 麻豆原创 Size (2018-2029)
6.2 North America Multiplex Molecular Diagnostic 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multiplex Molecular Diagnostic 麻豆原创 Size by Country (2018-2023)
6.4 North America Multiplex Molecular Diagnostic 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplex Molecular Diagnostic 麻豆原创 Size (2018-2029)
7.2 Europe Multiplex Molecular Diagnostic 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multiplex Molecular Diagnostic 麻豆原创 Size by Country (2018-2023)
7.4 Europe Multiplex Molecular Diagnostic 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiplex Molecular Diagnostic 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Multiplex Molecular Diagnostic 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multiplex Molecular Diagnostic 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Multiplex Molecular Diagnostic 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiplex Molecular Diagnostic 麻豆原创 Size (2018-2029)
9.2 Latin America Multiplex Molecular Diagnostic 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multiplex Molecular Diagnostic 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Multiplex Molecular Diagnostic 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplex Molecular Diagnostic 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Multiplex Molecular Diagnostic 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multiplex Molecular Diagnostic 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Multiplex Molecular Diagnostic 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Multiplex Molecular Diagnostic Introduction
11.1.4 BD Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.1.5 BD Recent Development
11.2 产颈辞惭茅谤颈别耻虫
11.2.1 产颈辞惭茅谤颈别耻虫 Company Detail
11.2.2 产颈辞惭茅谤颈别耻虫 Business Overview
11.2.3 产颈辞惭茅谤颈别耻虫 Multiplex Molecular Diagnostic Introduction
11.2.4 产颈辞惭茅谤颈别耻虫 Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.2.5 产颈辞惭茅谤颈别耻虫 Recent Development
11.3 SpeeDx
11.3.1 SpeeDx Company Detail
11.3.2 SpeeDx Business Overview
11.3.3 SpeeDx Multiplex Molecular Diagnostic Introduction
11.3.4 SpeeDx Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.3.5 SpeeDx Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Multiplex Molecular Diagnostic Introduction
11.4.4 Roche Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Contextual Genomics
11.5.1 Contextual Genomics Company Detail
11.5.2 Contextual Genomics Business Overview
11.5.3 Contextual Genomics Multiplex Molecular Diagnostic Introduction
11.5.4 Contextual Genomics Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.5.5 Contextual Genomics Recent Development
11.6 GenMark Diagnostics
11.6.1 GenMark Diagnostics Company Detail
11.6.2 GenMark Diagnostics Business Overview
11.6.3 GenMark Diagnostics Multiplex Molecular Diagnostic Introduction
11.6.4 GenMark Diagnostics Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.6.5 GenMark Diagnostics Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic Multiplex Molecular Diagnostic Introduction
11.7.4 Hologic Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.7.5 Hologic Recent Development
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Detail
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Multiplex Molecular Diagnostic Introduction
11.8.4 Luminex Corporation Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.8.5 Luminex Corporation Recent Development
11.9 Binx Health
11.9.1 Binx Health Company Detail
11.9.2 Binx Health Business Overview
11.9.3 Binx Health Multiplex Molecular Diagnostic Introduction
11.9.4 Binx Health Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
11.9.5 Binx Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

BD
产颈辞惭茅谤颈别耻虫
SpeeDx
Roche
Contextual Genomics
GenMark Diagnostics
Hologic
Luminex Corporation
Binx Health

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.